P
Pristem
Medtech company providing robust, cost-effective, easy and safe Medical Systems
About Pristem
Pristem is a startup that operates in the medical imaging sector, aiming to alleviate the global health burden by providing affordable and reliable medical imaging services. The company's primary focus is on X-ray imaging, a crucial diagnostic tool for various health conditions, including trauma, infectious diseases, and noncommunicable diseases. Pristem's services are particularly targeted towards underserved regions worldwide, where access to such technology is limited.
The company's flagship product is the Cristalix-T1, a general-purpose radiographic system with reviewing capabilities. This system is designed to be highly efficient, user-friendly, and reliable, allowing operators to acquire high-quality images while focusing on patient care. The Cristalix-T1 is equipped with an intuitive graphical user interface and over 100 built-in tutorials to guide operators through successful X-ray examinations.
Pristem's business model revolves around the integration of its technology into existing healthcare systems. The Cristalix-T1 can be integrated into any DICOM environment, either locally or through cloud-based PACS/RIS. The system also features a secure data management system with crash-proof, dual-disk data storage, and a virtual terminal application for web access to system data.
The company's approach to healthcare delivery is decentralized, with a network of centers located close to patients. This model allows for a wider variety of medical professionals to operate the machines, bringing healthcare closer to patients.
In terms of revenue, Pristem likely makes money by selling its Cristalix-T1 systems to healthcare providers and through ongoing service and maintenance contracts.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Lausanne, Switzerland
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 75.8/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Medical Imaging, Spinout, Sustainable Development Goals, Clinical Decision Support, Physician Support Tools, Health It
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Aug 2018 | $14M | $54M | Privegest | ↗ |
| SPINOUT✓Other financing | Dec 2015 | $0 | — | EPFL Swiss Federal Polytechnic School of Lausanne | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Pristem is 370 monthly website visits, up 5.7% over the last three months. Pristem's team grew 11.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Venture Kick
Series A1 investor entered at this stage
- PRPrivegest
Other known investors1 additional known investor
EPFL Swiss Federal Polytechnic School of Lausanne
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pristem on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pristem’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.